Abstract During reproductive aging female rats enter an anovulatory state of persistent estrus (PE). In an animal model of re-instatement of estrus cyclicity in middle-aged PE rats we injected the animals with progesterone (0.5 mg progesterone/kg body weight) at 12:00 for 4 days whereas control animals received corn oil injections. After the last injection animals were analyzed at 13:00 and 17:00. Young regular cycling rats served as positive controls and were assessed at 13:00 and 17:00 on proestrus. Progesterone treatment of middle-aged PE rats led to occurrence of luteinizing hormone (LH), follicle stimulating hormone (FSH), and prolactin surges in a subset of animals that were denoted as responders. Responding middle-aged rats displayed a reduction of ER-b mRNA in the preoptic area which was similar to the effect in young rats. Within the mediobasal hypothalamus, only young rats showed a decline of ER-a mRNA expression. A decrease of ER-a mRNA levels in the pituitary was observed in progesteroneresponsive rats and in young animals. ER-b mRNA expression was reduced in young regular cycling rats. ER-b mRNA levels in the ovary were reduced following progesterone treatment in PE rats and in young rats. Taken together our data show that cyclic administration of progesterone reinstates ovulatory cycles in intact aging females which have already lost their ability to display spontaneous cyclicity. This treatment leads to the occurrence of preovulatory LH, FSH and prolactin surges which are accompanied by differential modulation of ERs in the hypothalamus, the pituitary and the ovary.
Introduction
Reproductive aging in female rats is characterized by attenuation and delayed onset of the proestrus LH surges. These changes occur by the time the animals reach middle-age, i.e. at the age of 9-10 months (Cooper et al. 1980; Lu et al. 1985) . During this period animals change from a pattern of regular estrus cycles to irregular cycles with an extended estrus phase (Nass et al. 1984) . As rats age further, they enter an anovulatory state of persistent estrus (PE). The acyclic PE state is characterized by a lack of the preovulatory luteinizeing hormone (LH) surge, chronically elevated estradiol levels, and diminished progesterone secretion (Huang et al. 1978; Lu et al. 1979) . Whereas the loss of positive feedback of estradiol on LH secretion in PE rats is well established the implications of reduced progesterone levels are less clear.
A surge of prolactin occurs in female rats during proestrus in response to elevated steroid levels. Prolactin has primary or modulatory roles in the reproductive cycles of female mammals, and progesterone has been implicated in the feedback regulation of prolactin (Bole-Feysot et al. 1998; Freeman et al. 2000; Horseman et al. 1997) . The proestrus surge of prolactin in the rat plays a major role in maintaining the function of the corpus luteum after ovulation (Smith et al. 1975) . During most of the estrus cycle the secretion of LH and follicle-stimulating hormone (FSH) is maintained at a relatively low level by the negative feedback of estrogen and progesterone on the hypothalamic-pituitary-ovarian system (Fink 1988) . In contrast, the preovulaory gonadotropin surge results from a positive feedback cascade. Initially, estradiol secreted by the ovaries triggers a surge of gonadotropin releasing hormone (GnRH) and an increase in pituitary responsiveness to GnRH. In the rat, neurons that synthesize and secrete GnRH are mainly located in the preoptic area (POA) whereas axons terminate in the mediobasal hypothalamus/ median eminence area (MBH). The negative feedback control of the GnRH system could be accomplished by sex hormones acting on either cognate receptors expressed in GnRH neurons or on gonadal-steroid responsive systems upstream of GnRH. Thus, the regulation of estrogen receptors by sex steroids plays an important role in reproductive functions.
Within the ovary, estradiol is an essential hormone for ovulation. It has been demonstrated that rat granulosa cells both synthesize and respond to estrogen (Hsueh et al. 1984) . ER-b is the predominant ER form expressed in the granulosa cells of growing and mature follicles in the rodent ovary (Fitzpatrick et al. 1999; Sar and Welsch 1999) and ER-b knock out mice fail to exhibit efficient ovulation even when treated with exogenous gonadotropins (Couse and Korach 1999) .
Progesterone is intrinsic to the maintenance of ovulatory cyclicity through its positive and negative actions on the hypothalamo-pituitary unit (Fink 1988; Kalra 1993; Levine 1997) . The acute action of progesterone on proestrus is to cause a augmentation of the LH and FSH release action of GnRH (Krey and Kamel 1990; Lagace et al. 1980; Turgeon and Waring 1990) . Furthermore, expression of progesterone receptor (PR) has been described in the POA (Helena et al. 2006) and ovarian granulosa cells (Peluso 2004) indicating that progesterone might also exert biological functions on the level of the hypothalamus and the ovary.
The current study was designed to investigate the effect of progesterone in re-initiating estrus cyclicity in gonadally intact PE rats. We assessed responsiveness of the animals by measuring serum levels of LH, FSH, prolactin and estradiol on proestrus at 13:00 and 17:00. Young regular cycling rats served as positive controls. Secondly, we measured mRNA expression of ER-a and ER-b in the POA, MBH, pituitary, and ovary of these animals.
Materials and methods

Animals
The experimental procedures complied with the German animal welfare legislation. Young adult (3 months) and middle-aged (11-12 months) female Sprague Dawley rats (Winkelmann, Borchen, Germany) were used in this study. Animals were housed under standardized conditions (lights on from 06:00 to 18:00, 24°C room temperature, relative humidity of 30-70%). Regular laboratory diet (Sniff, Soest, Germany) and water were available ad libitum. All animals were monitored for estrous cyclicity by vaginal smears. Beginning at the age of 8 months, estrus cycles of the middle-aged rats were controlled. 20 days after onset of persistent estrus, animals were injected subcutaneously with 0.5 mg progesterone/kg body weight dissolved in corn oil at 12:00 h while control animals received injections with corn oil. Monitoring of vaginal cytology was continued. Animals were again injected with progesterone on the two following proestrus days at 12:00. At 13:00, control animals and animals treated with progesterone were killed by decapitation. At 17:00, animals that received corn oil injections and progesteronetreated animals were sacrificed. Young animals that served as controls for the middle-aged group were monitored for three consecutive 4 day cycles. On proestrus day, animals were decapitated under CO 2 anesthesia at 13:00 and at 17:00.
Based on the LH levels, progesterone (P) treated animals killed at 17:00 were grouped in those rats responding to steroid application with LH concentrations less than 5 ng/ml and animals which responded with a distinct LH peak, i.e. LH levels [5 ng/ml. The final assignment of animals to the experimental groups was (see also figures and respective legends): 13:00 -P (without P application at noon, 16 rats), 13:00 ?P (injected with P at noon, 16 rats) 17:00 -P (rats without P application at noon n = 16), ?P/LH \5 (rats injected with progesterone at noon, responding with LH levels less than 5 ng/ml at 17:00 20 rats); ?P/LH [5 (rats injected with progesterone at noon, responding with LH levels more than 5 ng/ml at 17:00 16 rats), Y13:00 and Y17:00: Young proestrus rats killed at 13:00 (16 rats) or 17:00 h (16 rats).
Hormone analysis
For determination of serum hormone levels by radioimmunoassay (RIA), blood was collected from the trunk. The blood samples were centrifuged (3000g, 20 min) and the serum was stored at -20°C for further analysis. LH, FSH, and prolactin were measured by a specific RIA supplied by the National Hormone and Pituitary Program of the NIH as described previously (Roth et al. 2001 ).
Tissue preparation
Following decapitation, the brain was removed from the skull and frozen immediately on dry ice. Pituitaries and ovaries were snap frozen in liquid nitrogen. All samples were stored at -70°C until further processing. Brains were sliced into serial frontal sections (600 lm in depth) on a cryostat. Micropunches of the POA were taken from frozen slices with a 1-mm-diameter stainless needle according to the method of Palkovits (1973) . The stereotactic coordinates were: A8.2, V7.5, L1.5. The MBH was cut out from the brain with a scalpel. The borders of the tissue pieces were the optic chiasm, the hypothalamic grooves and the mammillary bodies with a cut depth of 2 mm.
RNA extraction and reverse transcription
Extraction of total RNA from pituitaries and micropunches was performed using a RNeasy mini kit (Quiagen) according to the manufacturer 0 s guidelines. Reverse transcription was carried out in a total volume of 20 ll containing 19 reaction buffer (50 mM Tris-HCl, 75 mM KCl, 3 mM MgCl 2 , 50 mM DTT), 100 ng random hexamer primer, 0,5 mM dNTPs, 200 U M-MMLV Reverse Transciptase RNase H-(Promega), 4 U RNasin (Promega) 1-10 ll RNA and 1 ll mutant RNA. Samples were incubated for 10 min at 22°C to allow primer annealing, reverse transcription took place at 42°C for 50 min, finally RNA-cDNA hybrids were denatured for 10 min at 95°C.
Competitive RT-PCR
For generation of mutant RNA templates, composite primers were designed for each probe. An RT-PCR reaction was carried out with composite primer plus the respective sense or antisense primer and the resulting PCR products were cloned using the TOPO TA cloning kit (Invitrogen, Groningen, The Netherlands). After sequencing, the mutant RNA was reverse transcribed with the Reverse Transcription System purchased from Promega (Mannheim, Germany). PCR was conducted using Supermix (Gibco-BRL, Karlsruhe, Germany). Prior to RT reaction various amounts (10-100 fg) of mutant RNA were added to all reaction vials. The concentration of this cRNA was evaluated for each investigated gene by pilot titration experiments. For PCR reaction, 2-4 ll cDNA and 25 pM primer were added to the Supermix solution. PCR procedure was performed in a Biometra automated thermocycler (1 min 94°C, 1 min 60°C, 2 min 72°C). The program was run from 23 to 29 cycles. To destroy secondary structures, the PCR was continued with 5 cycles of 1 min at 78°C, 1 min at 60°C and 2 min at 72°C. Primers for ER-a were: Sense primer:
0 .Ten microliters of the amplified PCR products were size-fractionated by electrophoresis in a 1.5% agarose gel in TBE buffer and stained with ethidium bromide. Bands were visualized at 254 nm and photographed with a Kodak DC 120 camera. Dendsitometric PCR signals were evaluated with the Kodak DC 1D program (Eastman Kodak Co., NY., USA).
The arbitrary unit of each native DNA band was related to the corresponding mutant DNA value.
Statistical evaluation
All data are expressed as mean ? SEM. Results obtained from the two groups of young animals were analysed via t-test. The effects of progesterone treatment of middle-aged rats were evaluated via one-way ANOVA and post-hoc analysis was carried out using Dunnett's test (Prism software, GraphPad, La Jolla, CA). All differences were considered significant at P \ 0.05.
Results
To determine the effectiveness of progesterone in reinstating estrus cyclicity, we first assessed serum LH, FSH, and prolactin levels in middle-aged, gonadally intact PE rats as well as in young regular cycling rats (Fig. 1) . For this purpose, we examined (a) the effect of treatment at 13:00 and 17:00 and (b) the effect of time of day in progesterone-treated animals. Young regular cycling rats served as positive controls and were analyzed at 13:00 and 17:00.
Middle-aged rats studied at 13:00 showed low levels of LH that were not affected by progesterone treatment (Fig. 1a) . Middle-aged rats treated with progesterone and analyzed at 17:00 exhibited a differential response. Twenty animals showed no LH peak and had serum LH levels below 5 ng/ml (mean 0.53 ng/ml) and were therefore referred to as non-responders. In contrast, 16 rats exhibited LH concentrations above 5 ng/ml (mean: 15.3 ng/ml) and were denoted as responders. Young rats killed at 17:00 showed significantly elevated LH levels compared to animals harvested at 13:00. Similar results were obtained regarding serum FSH levels (Fig. 2b) . Middle-aged responding rats showed at 17:00 a significant increase in FSH concentrations compared to untreated rats or to progesterone-treated animals analyzed at 13:00 whereas non-responding rats exhibited only basal FSH levels. Progesterone treatment resulted in no change in FSH levels at 13:00. Young control animals exhibited a significant increase in FSH concentrations at 17:00 compared In this and the following figures the abbreviations are: 13:00 -P and 17:00 -P: middle-aged rats without progesterone application at noon; 13:00 ?P, 17:00 ?P: middle-aged rats with progesterone application at noon; 17 ?P/LH \5, rats injected with progesterone at noon, responding with LH levels less than 5 ng/ml at 17:00; ?P/LH [5, rats injected with progesterone at noon, responding with LH levels more than 5 ng/ml at 17:00; Y13:00 and Y17:00: Young proestrus rats killed at 13:00 or 17:00 h. Data are shown as mean ± SEM. * = P \ 0.05 versus -P, D = P \ 0.05 vs. 13:00 ?P, o = P \ 0.05 versus Y13:00 to 13:00. Prolactin levels showed a similar secretion profile as observed for the gonadotropins (Fig. 1c) . Middle-aged rats that responded to progesteronetreatment showed a significant elevation of prolactin levels at 17:00 compared to untreated controls or to progesterone-treated rats killed at 13:00. No effect of treatment was observed at 13:00. Young rats killed at 17:00 had significantly higher prolactin serum concentrations compared to age-matched animals killed at 13:00. Middle-aged, progesterone-treated rats that were killed at 13:00 showed an significant increase in serum estradiol levels compared to untreated rats whereas no effect of hormone treatment was observed in the 17:00 group of animals (Fig. 2) . Young regular cycling rats that served as positive controls showed a decrease in estradiol concentrations at 17.00 compared to 13:00.
We next investigated the mRNA expression for ER-a and ER-b in various tissues involved in regulation of the estrus cycle. mRNA levels for the ERs in the POA following progesterone treatment are depicted in Fig. 3 . ER-a mRNA expression was not affected by hormone treatment, age or time (Fig. 3a) . Regarding ER-b we observed significant down-regulation in middle-aged responding rats compared to untreated controls or compared to animals assessed at 13:00 (Fig 3b) . Accordingly, young animals showed a decrease in ER-b mRNA expression at 17:00 compared to 13:00. Figure 4 depicts mRNA levels for ERs in the hypothalamic area where GnRH axon terminals reside. In young regular cycling rats ER-a mRNA expression in the MBH was significantly downregulated at 17:00 compared to 13:00 (Fig. 4a) . This effect was abolished in PE rats irrespective of progesterone treatment. ER-b mRNA expression in the MBH was not affected by treatment, time or age (Fig. 4b) .
Furthermore, we assessed mRNA expression of both ERs in the anterior pituitary (Fig. 5) . Following progesterone treatment ER-a mRNA levels in middle-aged animals increased significantly at 13:00 compared to untreated controls (Fig. 5a ). Progesterone-treated animals analyzed at 17:00 showed a significant decrease in ER-a mRNA compared to hormone treated rats analyzed at 13:00. Consistently with these results young animals showed a decline in In this and the following figures mRNA expression of middleaged rats analyzed at 13:00 without progesterone treatment was set as 100% and the mean values of the other treatment groups were expressed in relation to this group. Data are shown as mean ± SEM. * = P \ 0.05 versus -P, D = P \ 0.05 vs. 13:00 ?P, o = P \ 0.05 versus Y13:00 ER-a mRNA expression at 17:00 compared to 13:00. A similar expression profile was observed for ERb in young animals whereas middle-aged rats exhibited no changes in ER-b mRNA expression (Fig. 5b) . We finally determined modulation of ERs in the ovary (Fig. 6 ). ER-a mRNA expression was not affected by treatment, time or age (Fig. 6a) . In middle-aged responding rats ER-b mRNA levels declined at 17:00 compared to progesterone-treated animals analyzed at 13:00 (Fig. 6b) . A similar effect was observed in young rats assessed at 17:00 compared to animals harvested at 13:00.
Discussion
The aim of this study was to reinstate estrus cyclicity in middle-aged intact PE rats via application of progesterone and to assess the regulation of ER-a and ER-b mRNA in the hypothalamo-pituitary-ovarian axis. To monitor responsiveness of our animals to hormone treatment we first assessed gonadotropin secretion. Remarkably, we observed differential modulation of LH and FSH secretion in middle-aged rats following progesterone application. Progesterone treatment led to the appearance of pronounced LH surges on the afternoon of proestrus in 16 out of 36 animals. These rats were therefore denoted as progesterone-responsive animals (LH secretion [5 ng/ml). In contrast, 20 animals did not respond to progesterone treatment and were therefore referred to as nonresponders (LH secretion \5 ng/ml). These data contrast data obtained by Tsai et al. (2004) who described that challenge with progesterone after estradiol priming of ovariectomized early PE rats reinstated LH surges in all rats that had become PE within 35 days. The discrepancy of these results might be explained by the fact that we investigated intact PE rats whereas the former study used ovariectomized, estradiol-primed animals. The rise in gonadotropin secretion observed in middle-aged PE rats on proestrus afternoon was preceded by an increase in plasma estradiol levels. Elevated estradiol levels are a prerequisite for the positive feedback action on gonadotropin secretion. Although it has been reported that in PE rats the gonadotropin surge response to the stimulation of estradiol is no longer effective (Day et al. 1988; Matt et al. 1987 ) our data reveal that in 44% of our animals application of progesterone in the presence of endogenous estradiol led to the re-ocurrence of gonadotropin peaks. In addition, we observed an increase of prolactin on proestrus afternoon in young regular cycling rats and in progesterone-responsive middle aged rats. The preovulatory prolactin surge has been implicated in maintenance of corpus luteum functions and gene disruption of the mouse prolactin gene caused infertility in female mice (Horseman et al. 1997) . Since lactotropes in the rat lack PR expression (Fox et al. 1990) , it has been suggested that progesterone might exert indirect functions on lactotropes via actions on gonadotropes (Freeman et al. 2000) . However, most studies investigating the site of progesterone action in modulating prolactin secretion have focused on the hypothalamus. For example, progesterone has been shown to affect prolactin secretion through its actions on the tuberoinfundibular dopamine system (Arbogast and Voogt 1994; Kohama and Bethea 1995) . The significance of the hypothalamic action of progesterone in the regulation of prolactin secretion results in advancing or prolonging the estradiol-induced prolactin surge (Arbogast and Ben-Jonathan 1990; Caligaris et al. 1974; Yen and Pan 1998) . In addition, POA neurons have been implicated in the control of prolactin secretion since lesion of this area blocks the prolactin peak induced by estradiol in ovariectomized rats (Pan and Gala 1985) , and electric stimulation of the POA increases prolactin secretion in male rats (Colombo 1984) .
During the reproductive cycle in the female progesterone modulates gonadotropin secretion at the level of the pituitary gland, as well as the hypothalamaus (Fink 1988; Kalra 1993) . At the level of the pituitary gland, progesterone has been shown to regulate the magnitude and possibly the duration of the preovulatory gonadotropin surge (Banks and Freeman 1978; Krey and Kamel 1990; Turgeon and Waring 1990) . In agreement with these results, Bellido et al. (2002) reported that LH and FSH secretion were reduced by application of the antiprogestin RU486 to isolated pituitaries. As RU486 reduces galanin (Sanchez-Criado et al. 2001 ) and activin (Szabo et al. 1998 ) stimulating effects on LH and FSH secretion, progesterone treatment appears to exert direct effects on the pituitary. Further evidence for this action is provided by the fact that upregulation of the PR by estrogen in the pituitary has been demonstrated by several reports (Bethea et al. 1996; Szabo et al. 2000; Turgeon et al. 1999) . In rats, localization of the PR within the pituitary gland is restricted to gonadotropes (Fox et al. 1990; Turgeon et al. 1999) . Thus, progesterone might increase the responsiveness of gonadotropes to GnRH or increase the production and secretion of LH and FSH.
The observed regulation of LH and FSH secretion might also be affected on the level of the hypothalamus. The progesterone-induced LH surge in the estrogen-primed rat is thought to be mediated through interneurons since GnRH neurons lack PRs (Fox et al. 1990 ). The inhibitory neurotransmitter gamma-aminobutyric acid (GABA) is converted from glutamate by the rate-limiting enzyme glutamic acid decarboylase (GAD). It has been demonstrated that progesterone treatment decreases GAD67 mRNA expression in the POA on proestrus at a time when LH peaks occur (Unda et al. 1995) . Since furthermore the vast majority of cells containing PR immunoreactivity in the POA showed ER immunoreactivity (Warembourg et al. 1989) we next addressed the question how ER mRNA expression in the POA was regulated by progesterone. Our findings reveal that ER-b mRNA expression in young rats and middle-aged responding rats was down-regulated on the afternoon of proestrus whereas ER-a mRNA levels remained unchanged. It has been demonstrated that disruption of the ER-a did not completely inhibit the induction of PR in the POA (Moffatt et al. 1998 ). This suggests that the induction of PR in ERa-knockout mice may also be mediated by ER-b. Furthermore it has been demonstrated that GnRH neurons are immunopositive for ER-b (Kallo et al. 2001) indicating that ER-b might be responsible for mediating the estrogenic effect on GnRH secretion preceding the progesterone-induced LH peak. The observation that the dynamics in the expression pattern for ER-b were not affected by age in the responding rats might provide a prerequisite for the re-establishment of estrus cyclicity.
Another cell population involved in regulating GnRH release are estrogen-receptive neurons located in the MBH (Caraty et al. 1998) . Within this region we observed significant down regulation of ER-a at 17:00 in young animals. It has been described that gonadotropin-inhibitory neurons which are ER-a positive and respond to estrogens are located in the MBH of mammals (Kriegsfeld et al. 2006) . Since in vivo gonadotropin inhibitory hormone administration rapidly inhibits LH secretion, a down-regulation of ER-a might lead to decreased sensitivity of these neurons to estrogens resulting in increased LH secretion. In addition, as many ER-expressing cells synthesize GABA (Herbison et al. 1993) , decreased responsiveness to estradiol in the MBH of young animals may lead to increased LH secretion via a GABAergic mechanism. Since the differential expression of ER-a was restricted to young animals we assume that the age-related loss of ER-a mRNA decrease in the MBH may account for the decrease in LH secretion in middle-aged responding (15.3 ng/ml) compared to young (22.8 ng/ml) rats.
We next assessed expression of both ERs in the pituitary. Our data reveal that in young control animals ER-a mRNA expression was significantly decreased at 17:00 compared to 13:00. We also observed an effect of progesterone treatment and time in middle-aged rats. Progesterone application led to a transient increase in ER-a expression at 13:00 and a decrease at 17:00. It has been demonstrated that ER-a is the predominant form of ERs in the pituitary (Scully et al. 1997 ) and ER-a is expressed in high levels in lactotropes and gonadotropes (Mitchner et al. 1998) . Therefore, the high levels of ER-a observed in young rats and middle-aged progesterone-treated animals at 13:00 might be partly responsible for the observed prolactin and LH surges. In addition, our data are in agreement with results obtained by Sanchez-Criado et al. (2005) who report that the proportion of ER-a positive cells co-localizing with LH vary with the estrus cycle being highest on proestrus. ER-b, in contrast, showed only significant down-regulation at 17:00 in young animals. Since disruption of the ER-b gene has little effect on pituitary function in ERknockout models (Couse and Korach 1999) it is likely that this receptor is of minor importance regarding gonadotropin and prolactin secretion.
Since ovarian follicular development is primarily dependent on pituitary gonadotropins and estradiol, we next examined the differential expression of ERs in the ovary. We observed down regulation of ER-b mRNA expression in young animals at and in middleaged responding rats at 17:00 whereas ER-a mRNA levels were not affected by progesterone treatment. The prevailing form of ER in the ovary is ER-b (Byers et al. 1997) and ER-b is expressed predominantly in granulosa cells (Fitzpatrick et al. 1999; O'Brien et al. 1999; Sar and Welsch 1999) . Several reports document that high levels of LH decrease steady-state ER-b mRNA levels in the granulosa cells of preovulatory follicles in vivo, as well as in granulosa cells cultured in vitro (Byers et al. 1997; Guo et al. 2001; O'Brien et al. 1999) . Furthermore, the preovulatory gonadotropin surge has been shown to induce the transcription of the PR gene in granulosa cells (Clemens et al. 1998; Park-Sarge and Mayo 1994; Park-Sarge and Sarge 1995) . Thus, it might be possible that LH decreases ER-b mRNA expression via upregulation of PR.
Taken together our data show that cyclic administration of progesterone reinstates ovulatory cycles in intact aging females which have already lost their ability to display spontaneous cyclicity. This treatment leads to the occurrence of preovulatory LH and prolactin surges which are accompanied by differential modulation of ERs in the hypothalamus, the pituitary and the ovary.
